Amylyx Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 05/15/2025 | 7.87 M | $27.88 M | 16.24% | 9.19% |
| TCG CROSSOVER MANAGEMENT, LLC | 05/14/2025 | 5.94 M | $21.04 M | 27.99% | 6.94% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 5.70 M | $20.17 M | 100.00% | 6.65% |
| VANGUARD GROUP INC | 05/09/2025 | 4.12 M | $14.57 M | 52.89% | 4.80% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 3.08 M | $10.91 M | 418.62% | 3.60% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 2.93 M | $10.39 M | 102.07% | 3.42% |
| CITADEL ADVISORS LLC | 05/15/2025 | 2.76 M | $9.76 M | 39.94% | 3.22% |
| ABRDN PLC | 05/13/2025 | 2.43 M | $8.60 M | 41.07% | 2.84% |
| SATURN V CAPITAL MANAGEMENT LLC | 05/15/2025 | 2.43 M | $8.59 M | 172.92% | 2.83% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 2.41 M | $8.54 M | 24.94% | 2.81% |
| BLACKROCK, INC. | 05/02/2025 | 2.39 M | $8.45 M | 4.76% | 2.79% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 2.00 M | $7.09 M | 7.69% | 2.34% |
| GREAT POINT PARTNERS LLC | 05/15/2025 | 1.81 M | $6.41 M | 100.00% | 2.11% |
| WOODLINE PARTNERS LP | 05/15/2025 | 1.61 M | $5.70 M | 100.00% | 1.88% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.47 M | $5.21 M | 100.00% | 1.72% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 1.47 M | $5.21 M | 69.39% | 1.72% |
| UBS GROUP AG | 05/13/2025 | 1.39 M | $4.92 M | 115.75% | 1.62% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/12/2025 | 1.20 M | $4.25 M | -5.04% | 1.40% |
| FMR LLC | 05/12/2025 | 1.16 M | $4.10 M | 58.33% | 1.35% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 942.89 K | $3.34 M | 20.80% | 1.10% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 916.97 K | $3.25 M | 100.00% | 1.07% |
| PFM HEALTH SCIENCES, LP | 05/15/2025 | 834.14 K | $2.95 M | 100.00% | 0.97% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 806.16 K | $2.85 M | 41.95% | 0.94% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 794.35 K | $2.81 M | -67.26% | 0.93% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 762.05 K | $2.70 M | 16.97% | 0.89% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2025 | 750.41 K | $2.66 M | -8.87% | 0.88% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 649.80 K | $2.30 M | 169.18% | 0.76% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 570.86 K | $2.02 M | 0.00% | 0.67% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 515.10 K | $1.82 M | 10.92% | 0.60% |
| MORGAN STANLEY | 05/15/2025 | 474.42 K | $1.68 M | 2.20% | 0.55% |
| CITIGROUP INC | 05/12/2025 | 463.24 K | $1.64 M | -23.97% | 0.54% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 372.85 K | $1.32 M | 24.72% | 0.44% |
| ORBIMED ADVISORS LLC | 05/15/2025 | 348.00 K | $1.23 M | 0.00% | 0.41% |
| JANE STREET GROUP, LLC | 05/19/2025 | 331.19 K | $1.17 M | -56.73% | 0.39% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 290.68 K | $1.03 M | 38.61% | 0.34% |
| D. E. SHAW & CO., INC. | 05/15/2025 | 270.01 K | $955.82 K | -11.98% | 0.32% |
| ALLOSTERY INVESTMENTS LP | 05/15/2025 | 266.10 K | $941.99 K | 100.00% | 0.31% |
| STATE STREET CORP | 05/15/2025 | 261.78 K | $926.71 K | 19.87% | 0.31% |
| ALDEBARAN CAPITAL, LLC | 05/13/2025 | 259.25 K | $917.76 K | -1.33% | 0.30% |
| WALLEYE CAPITAL LLC | 05/14/2025 | 250.89 K | $888.14 K | -51.64% | 0.29% |
| MARSHALL WACE, LLP | 05/15/2025 | 247.28 K | $875.35 K | 33.90% | 0.29% |
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 242.11 K | $855.00 K | -60.44% | 0.28% |
| FEDERATED HERMES, INC. | 05/08/2025 | 202.79 K | $717.86 K | 0.23% | 0.24% |
| 05/06/2025 | 202.74 K | $717.71 K | 50.80% | 0.24% | |
| ALPHA WAVE GLOBAL, LP | 05/14/2025 | 187.31 K | $663.08 K | 26.03% | 0.22% |
| OMERS ADMINISTRATION CORP | 05/14/2025 | 169.60 K | $600.38 K | 156.97% | 0.20% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 155.70 K | $551.18 K | 6.28% | 0.18% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 148.56 K | $525.90 K | 195.65% | 0.17% |
| BANK OF MONTREAL /CAN/ | 05/13/2025 | 143.51 K | $508.03 K | 0.00% | 0.17% |
| NORTHERN TRUST CORP | 05/13/2025 | 139.33 K | $493.24 K | 30.75% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Amylyx Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 157 institutional investors and hedge funds held shares of Amylyx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
PERCEPTIVE ADVISORS LLC: 7.87 M
TCG Crossover Management, LLC: 5.94 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 5.7 M
VANGUARD GROUP INC: 4.12 M
MILLENNIUM MANAGEMENT LLC: 3.08 M
Nantahala Capital Management, LLC: 2.93 M
83.33% of Amylyx Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 73.39 M shares in the last 24 months. This purchase volume represents approximately $405.09 M in transactions.